Adalimumab every other week combined with dexamethasone pulses for the treatment of refractory hidradenitis suppurativa

被引：3
|
作者：
Molina-Leyva, Alejandro [1 ]
机构：
[1] Hosp Univ Virgen Nieves, Hidradenitis Suppurat Clin, Dermatol Dept, Granada, Spain
来源：
DERMATOLOGIC THERAPY | 2019年 / 32卷 / 03期
关键词：
D O I：
10.1111/dth.12885
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Severe refractory hidradenitis suppurativa: treatment with ixekizumab, two case reports
    Cotter, C.
    Tobin, A. M.
    O'Connor, R.
    Gallagher, C.
    Connolly, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 : 70 - 70
  • [42] Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice
    Calvo Moya, Marta
    Gonzalez Lama, Yago
    Ruiz Antoran, Belen
    Omella Usieto, Ignacio
    el Hajra Martinez, Ismael
    Santos Perez, Elena
    Menchen Viso, Belen
    Matallana Royo, Virginia
    Gonzalez Partida, Irene
    Tellez de Meneses, Rocio de Lucas
    Bella Castillo, Pablo
    Gonzalez Rodriguez, Macarena
    Vera Mendoza, Maria Isabel
    CROHNS & COLITIS 360, 2023, 5 (01)
  • [43] Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy
    Arenbergerova, Monika
    Gkalpakiotis, Spyridon
    Arenberger, Petr
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (12) : 1445 - 1449
  • [44] Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
    Blaszczak, Alecia
    Trinidad, John C. L.
    Cartron, Alexander M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E31 - E31
  • [45] Adalimumab (ADA) treatment of hidradenitis suppurativa (HS) in a Crohn's disease (CD) patient
    Wenzke, Jeffrey T.
    Shah, Ashok
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S408 - S408
  • [46] The efficacy of modifying adalimumab 40 mg weekly to adalimumab 80 mg every two weeks for hidradenitis suppurativa: a multicenter retrospective cohort study
    Bassas-Vila, J.
    Vilarrasa, E.
    Bittencourt, F.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 : 46 - 46
  • [47] Disparate results in studies of adalimumab in the treatment of hidradenitis suppurativa: comment on the article by Amano etal
    Blanco, Ricardo
    Gonzalez-Lopez, Marcos A.
    Carmen Gonzalez-Vela, Maria
    Fernandez-Llaca, Hector
    Gonzalez-Gay, Miguel A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (03) : 380 - 381
  • [48] Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate
    Genovese, G.
    Caorsi, R.
    Moltrasio, C.
    Marzano, A. V.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 40 - 41
  • [49] Low-dose adalimumab biosimilar (ZRC-3197) in the treatment of hidradenitis suppurativa
    Patil, Sharmila
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2018, 84 (06): : 745 - 747
  • [50] Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
    Martora, Fabrizio
    Marasca, Claudio
    Cacciapuoti, Sara
    Fariello, Federica
    Potestio, Luca
    Battista, Teresa
    Scalvenzi, Massimiliano
    Megna, Matteo
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 159 - 166
12345